Skip to content

Tumour Localisation With Magnetic Clip Before Neoadjuvant Chemotherapy.

Tumour Localisation With Magnetic Clip Before Neoadjuvant Chemotherapy. A Randomised Pilot Feasibility Study: MagLocal 1.0

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06463600
Acronym
MagLocal
Enrollment
44
Registered
2024-06-18
Start date
2024-02-01
Completion date
2025-12-31
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Conserving Surgery

Keywords

Breast cancer, Tumour localisation, Magnetic clip, magnetic tracer, Preoperative chemotherapy

Brief summary

The feasibility of the use of magnetic clips for tumour localisation before preoperative chemotherapy in combination with superparamagnetic iron oxide nanoparticles (SPIO) as tracer for sentinel lymph node (SLN) detection and in combination with a magnetic clip in the index lymph node metastasis is studied.

Detailed description

The overall aim is to demonstrate that the use of magnetic clips for tumour localisation before preoperative chemotherapy is feasible at breast cancer surgery and histopathological evaluation in combination with superparamagnetic iron oxide nanoparticles (SPIO) as tracer for sentinel lymph node (SLN) detection, and in combination with a magnetic clip in the index lymph node metastasis if targeted axillary surgery is planned.

Interventions

DEVICEMagseed

Tumour localizer

DEVICEMetallic clip and guide wire

Tumour localizers

Sponsors

Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

One part feasibility and one part randomised.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age above 18 years 2. Planned for preoperative chemotherapy before breast cancer surgery 3. Planned breast conserving surgery with targeted axillary dissection or sentinel lymph node biopsy using magnetic technique 4. SLN-biopsy with magnetic tracer or targeted axillary dissection using magnetic tracer and Magseed 5. Signed and dated written informed consent before the start of specific protocol procedures

Exclusion criteria

1. Pregnant or breast-feeding 2. Iron overload disease 3. Known hypersensitivity to iron or dextran compounds 4. Inability to understand given information and give informed consent or undergo study procedures 5. Planned MRI control for tumour response during chemotherapy

Design outcomes

Primary

MeasureTime frameDescription
Specimen volumePerioperativelyThe surgical specimen is weighed after removal.

Countries

Sweden

Contacts

Primary ContactFredrik Warnberg, prof
fredrik.warnberg@vgregion.se+46706146251
Backup ContactKian Chin, MD
kian.chin@vgregion.se+46702316011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026